Type a term, then click a field below.

Search | advanced search

keepers


Type a term, then click a field below.

Search | simple search





1 subtopic

 

  • Replication Origin

RepliconFollow by RSS 

You've reached a pubget topic page. Below are the latest papers on this topic, with subtopics on the left.

keywords > Genetic Phenomena > Genetic Structures > Genome > Genome Components > Replicon

Latest papers

[Suppression of hepatitis C virus (HCV) replication with serine palmitoyltransferase inhibitor].

An N-terminal region of Lassa virus L protein plays a critical role in transcription but not replication of the virus genome.

[Evaluation and application of natural products for viral infections].

Combination therapy for hepatitis C virus with heat-shock protein 90 inhibitor 17-AAG and proteasome inhibitor MG132.

Identification of hepatitis C virus NS5A inhibitors.

A novel class of meso-tetrakis-porphyrin derivatives exhibits potent activities against hepatitis C virus genotype 1b replicons in vitro.

MK-7009, a potent and selective inhibitor of hepatitis C virus NS3/4A protease.

SH2 modified STAT1 induces HLA-I expression and improves IFN-γ signaling in IFN-α resistant HCV replicon cells.

[Identification and construction of replicon vectors of Japanese encephalitis virus (strain SA14-14-2)].

Nonstructural 5A protein activates β-catenin signaling cascades: Implication of hepatitis C virus-induced liver pathogenesis

[Construction and application of a novel shuttle expression vector based on haloarchaeal plasmid pSCM201].

[Construction of minireplicon of human respiratory syncytial virus].

Cholesterol biosynthesis modulation regulates dengue viral replication.

Optimisation of a mycobacterial replicon increases foreign antigen expression in mycobacteria.

Replicon Dynamics, Dormant Origin Firing, and Terminal Fork Integrity after Double-Strand Break Formation

[Construction and identification of replicon vector derived from an infectious full-length cDNA clone of a Sindbis virus].

HCV796: A selective nonstructural protein 5B polymerase inhibitor with potent anti-hepatitis C virus activity in vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus.

DNA vaccines for the prevention and treatment of allergy.

Generation and analysis of recombinant Bunyamwera orthobunyaviruses expressing V5 epitope-tagged L proteins

Inhibition of HCV replication by small interfering RNA.

page 1 2 3 4 5 6 7 8 9 10 11 ...